| Literature DB >> 30065450 |
Li-Tan Yang1,2, Wei-Chuan Tsai2, Chwan-Yau Luo3, Yi-Heng Li2, Liang-Miin Tsai2.
Abstract
BACKGROUND: Impaired left atrial (LA) reservoir deformation has been found to be associated with poor functional capacity and outcomes in severe chronic mitral regurgitation (MR). Among patients with primary MR (valve incompetence due to mitral valve pathology), we focus on Carpentier II classification (prolapse or flail mitral valve) and aim to investigate determinants for decreased LA reservoir deformation and its impact on LA remodeling in severe MR.Entities:
Keywords: left atrium; mitral regurgitation; speckle-tracking echocardiography; strain rate
Year: 2016 PMID: 30065450 PMCID: PMC6029286 DOI: 10.1016/j.jmu.2016.09.003
Source DB: PubMed Journal: J Med Ultrasound ISSN: 0929-6441
Figure 1Study flow diagram–dpatients included and excluded from the study. EF = ejection fraction; LV = left ventricular; LVEF = left ventricular ejection fraction; MR = mitral regurgitation; MV = mitral valve; NYHA = New York Heart Association functional classification;
Figure 2Left atrial strain curve derived from speckle-tracking echocardiographyd–the peak reservoir strain (LAεR) can be obtained from both apical four-chamber and apical two-chamber views. The white arrows indicate LAεR of the (A) basal septal and (B) basal inferior walls. LAεR = left atrial reservoir strain.
Baseline characteristics of 159 patients.
| Variable | |
|---|---|
| Age (y) | 57.3 ± 15.7 |
| Men | 108 (68) |
| Heart rate (beats/min) | 75.1 ± 14.3 |
| Hypertension | 93 (58) |
| Diabetes mellitus | 17 (11) |
| Atrial fibrillation | 25 (16) |
| Coronary artery disease | 10 (6) |
| Smoking | 21 (13) |
| Hyperlipidemia | 58 (36) |
| LVEDD (cm) | 5.7 ± 0.6 |
| LVESD (cm) | 3.3 ± 0.6 |
| LVESDi (cm/m2) | 1.9 ± 0.4 |
| LVMi (g/m2) | 115.7 ±31.0 |
| LVEF (%) | 72.7 ±6.7 |
| LV GLS (%) | -20.4 ±4.7 |
| 12.1 ±4.0 | |
| LAVi (mL/m2) | 48.6 ±33.1 |
| LAEi | 1.2 ± 0.2 |
| LAEF (%) | 44.6 ± 14.7 |
| LAεR (%) | 27.5 ± 10.4 |
| LASRR (1/s) | 2.25 ±0.64 |
| PASP (mmHg) | 37.2 ±19.0 |
| EROA (cm2) | 0.92 ±0.6 |
| Regurgitant fraction (%) | 58.1 ± 17.8 |
| Regurgitant volume (mL/beat) | 125.9 ±66.0 |
Data are expressed as mean ± SD or n (%).
E/e′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; EROA = effective regurgitant orifice area; LAEF = left atrial ejection fraction; LAEi - = left atrial eccentricity index; LAVi = left atrial volume index; LAɛR = left atrial reservoir strain; LASRR = left atrial reservoir strain rate; LVEDD = left ventricular end-diastolic dimension; LVEF = left ventricular ejection fraction; LVESD = left ventricular end-systolic dimension; LVESDi = left ventricular endsystolic dimension index; LV GLS = global left ventricular peak systolic longitudinal strain; LVMi = left ventricular volume index; PASP = pulmonary arterial systolic pressure; SD = standard deviation.
Correlates for decreased left atrial reservoir function.
| LA ɛR | LASRR | ||
|---|---|---|---|
| Continuous variables | Pearson correlation | coefficient ( | |
| Age | −0.507** | −0.392** | |
| Heart rate | −0.146 | −0.090 | |
| LVESDi | -0.018 | −0.007 | |
| LVEF | 0.019 | 0.071 | |
| LV GLS | −0.379** | −0.462** | |
| LVMi | −0.285** | −0.394** | |
| E/ | −0.373** | −0.235** | |
| LAEi | −0.292** | −0.257** | |
| LAEF | 0.514** | 0.602** | |
| LAVi | −0.287** | −0.463** | |
| PASP | −0.341** | −0.319** | |
| EROA | −0.071 | −0.091 | |
| Regurgitant volume | −0.118 | −0.190 | |
| Regurgitant fraction | 0.107 | 0.042 | |
| Categorical variables | |||
| Atrial fibrillation | yes | 19.7 ± 10.3*** | 1.68 ± 0.6*** |
| No | 28.9 ± 9.8 | 2.35 ± 0.6 | |
| NYHA | |||
| I ( | 29.5 ± 10.6* | 2.26 ± 0.6 | |
| II ( | 25.9 ±10.1 | 2.24 ± 0.7 | |
| Diabetes | Yes | 21.2 ± 7.7** | 1.97 ± 0.5 |
| Mellitus | No | 28.4 ± 10.5 | 2.30 ± 0.6 |
| Hypertension | Yes | 24.8 ± 9.2*** | 2.11 ± 0.6** |
| No | 31.2 ± 11.0 | 2.44 ± 0.7 |
* p < 0.05.
** p < 0.01.
*** p < 0.001.
E/e′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; EROA = effective regurgitant orifice area; LAEF= left atrial ejection fraction; LAEi - = left atrial eccentricity index; LAVi = left atrial volume index; LA ɛR= left atrial reservoir strain; LVEF = left ventricular ejection fraction; LVESDi = left ventricular end-systolic dimension index; LV GLS = global left ventricular peak systolic longitudinal strain; LVMi = left ventricular volume index; NYHA = New York Heart Association functional classification; PASP = pulmonary arterial systolic pressure.
Clinical and echocardiographic parameters between patients with or without accelerated LA remodeling.
| Available follow-up echo | Rapid LA remodeling | Slower LA remodeling | |
|---|---|---|---|
| Age (y) | 56.2 ± 15.8 | 60.6 ± 17.3* | 51.2 ± 12.3 |
| Men | 34 (57) | 14 (52) | 19 (68) |
| Hypertension | 34 (57) | 14 (52) | 18 (64) |
| Diabetes mellitus | 6 (12) | 2 (7) | 3 (11) |
| Atrial fibrillation | 6 (10) | 5 (19)* | 1 (4) |
| Coronary artery disease | 4 (7) | 2 (7) | 2 (7) |
| Hyperlipidemia | 26 (43) | 10 (37) | 15 (54) |
| NYHA I | 31 (52) | 11 (41) | 14 (50) |
| Heart rate (beats/min) | 73.6 ± 9.6 | 71.6 ± 10.9 | 75.4 ± 7.4 |
| LVEDD (mm) | 5.8 ± 0.7 | 5.7 ± 0. | 5.8 ± 0.5 |
| LVESD (mm) | 3.4 ± 0.6 | 3.2 ± 0.5 | 3.4 ± 0.5 |
| LVESDi (mL/m2) | 2.0 ± 0.3 | 1.9 ± 0.3 | 1.9 ± 0.3 |
| LVEF (%) | 72.7 ± 7.4 | 74.1 ± 8.3 | 71.4 ± 6.6 |
| LV GLS (%) | −20.6 ± 4.2 | −20.4 ± 5.0 | −20.7 ± 3.5 |
| LVMi (g/m2) | 114.3 ± 32.5 | 121.3 ± 39.3 | 106.2 ± 22.8 |
| E/e′ | 12.0 ± 4.2 | 13.4 ± 4.5* | 10.6 ± 3.1 |
| LAVi (mL/m2) | 49.5 ± 46.6 | 58.2 ± 63.5 | 40.7 ± 15.5 |
| LAEi | 1.2 ± 0.1 | 1.24 ± 0.15 | 1.16 ± 0.13 |
| LAEF (%) | 45.5 ± 15.5 | 41.5 ± 17.4 | 49.4 ± 11.1 |
| LA ɛR (%) | 29.1 ± 9.6 | 26.4 ± 11.0 | 31.2 ± 7.7 |
| LASRR (1/s) | 2.39 ± 0.55 | 2.30 ± 0.66 | 2.40 ± 0.41 |
| ΔLA′RɛR (%) | −0.88 ± 8.4 | −1.41 ± 7.78 | −1.35 ± 9.03 |
| ΔLASRR (1/s) | −0.15 ± 0.62 | −0.41 ± 0.45* | 0.14 ± 0.59 |
| PASP (mmHg) | 32.6 ± 16.0 | 38.0 ± 18.0* | 26.3 ± 10.1 |
| EROA (cm2) | 0.89 ± 0.4 | 0.74 ± 0.39 | 0.97 ± 0.49 |
| Regurgitant fraction (%) | 56.9 ± 16.5 | 53.7 ± 17.3 | 59.8 ± 14.9 |
| Regurgitant volume (mL/beat) | 121.3 ± 62.4 | 110.2 ± 52.9 | 126.1 ± 75.1 |
The symbol Δ represents the change between baseline and follow-up echocardiography (follow-up minus baseline parameters) * p < 0.05 between those with and without accelerated LA remodeling.
E/e′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; EROA = effective regurgitant orifice area; LA = left atrial; LAEF = left atrial ejection fraction; LAEi = left atrial eccentricity index; LAVi = left atrial volume index; LA ɛR = left atrial reservoir strain; LASRR = left atrial reservoir strain rate; LVEDD = left ventricular end-diastolic dimension; LVEF = left ventricular ejection fraction; LVESD = left ventricular end-systolic dimension; LVESDi = left ventricular end-systolic dimension index; LV GLS = global left ventricular peak systolic longitudinal strain; LVMi = left ventricular volume index; NYHA = New York Heart Association functional classification; PASP = pulmonary arterial systolic pressure.
Multivariate logistic regression analysis for determinants of accelerated left atrial remodeling.
| OR (95% CI) | ||
|---|---|---|
| Age (y) | 0.985 (0.916e1−058) | 0.671 |
| Atrial fibrillation | 7.079 (0.514e97−471) | 0.144 |
| 1.001 (0.771e1−300) | 0.995 | |
| PASP (mmHg) | 1.088 (0.989e1−196) | 0.082 |
| LVEF(%) | 1.082(0.955e1−225) | 0.216 |
| LAVi (mL/m2) | 1.007 (0.978e1−037) | 0.627 |
| ΔLASR (1/s) | 0.037 (0.003e0−496) | 0.013 |
The symbol Δ represents the change between baseline and follow-up echocardiography (follow-up minus baseline parameters).
CI = confidence interval; E/e′ = early transmitral velocity to tissue Doppler mitral annular early diastolic velocity ratio; LAVi = left atrial volume index; LASRR = left atrial reservoir strain rate; LVEF = left ventricular ejection fraction; OR = odds ratio; PASP = pulmonary arterial systolic pressure.